NL-3454 PV De Meern
Founded in 1987, Aspect™ Medical System's (NASDAQ: ASPM) mission was to develop technology that could measure a then unknown element of patient status - the direct effect of drugs and diseases on the brain. Today, Aspect is recognized as a pioneer and global market leader in brain monitoring, having led the way to develop proprietary technologies that directly measure these effects and ultimately improve the quality and cost effectiveness of patient care.
Aspect's premier product - Bispectral Index™ (BIS™) technology -became the first clinically proven and commercially available direct measure of the effects of anesthetics and sedatives on the brain.
At present an estimated 20 million patients undergo surgery with general anesthesia or deep sedation each year in the United States, and an additional 30 million in Europe and Japan. BIS technology allows medical professionals, for the first time, to reliably gauge the precise amount of drug required by each patient, resulting in better overall patient care and fewer undesirable events.
BIS technology is incorporated into all of Aspect's products, which are granted the CE mark and are distributed in the U.S. through both direct field representatives and a regional distributor network. The international division, headquartered in De Meern, The Netherlands is responsible for sales, distribution and clinical support outside the U.S. Aspect's core products include:
The BIS XP system, Aspect's newest generation consciousness monitoring technology
BIS Sensors, comprised of a one-piece, disposable strip placed on the patient's forehead to acquire the EEG signals needed for the BIS index (adult and pediatric sensors are available)
The A-2000™ BIS Monitor
The BIS Module kit, designed to allow easy integration of BIS technology into other patient monitors
The A-2000 Printer which attaches to the A-2000 monitor enabling easy training, case follow-up and an anesthesia record
The A-1050 EEG Monitor with Bispectral Index technology
Aspect Medical Systems is committed to enhancing the quality of patient care through groundbreaking technology, education and training. To assist healthcare professionals across the globe in incorporating BIS into routine practice, Aspect employs a full-time medical director and a host of trained field representatives who provide education and training on a regular basis. All Aspect employees share a deep committment to the success of the company and its mission. Moreover, the Company is guided by a management team skilled in many different facets of the healthcare and medical device industry.
Aspect continues to enhance and refine its product offerings and explore new capabilities for BIS technology to better meet the needs of patients and the healthcare teams who care for them. To that end, the company continues to conduct research to examine new applications and opportunities for BIS monitoring in the OR, ICU and special procedure environments. Additionally, Aspect is investigating how extensions of BIS technology may bring greater understanding to the diagnosis and treatment of diseases of the brain such as Alzheimer's disease.